Press Release
Abu Dhabi’s M42 is at the forefront of the shift from reactive to proactive healthcare.
Earlier this year, women in the UAE gained the ability to extend their fertility or delay menopause using an innovative technique known as ovarian tissue cryopreservation (OTC).
The procedure was made available thanks to a partnership between Abu Dhabi-based health provider M42 and the UK’s ProFaM, which developed OTC. The deal is the latest in a string of international partnerships forged by M42, emblematic of the strides it’s taking in the shift from traditional, reactive medicine, towards proactive, preventative healthcare. From innovative treatments like OTC to data-driven, personalized genomic medicine, these organizations offer a glimpse into the near-future of healthcare.
We partner with prominent health insurers to offer healthcare coverage for our patients.
Conveniently located in Rabdan, Abu Dhabi, offers a welcoming environment for women and children seeking exceptional healthcare.
We offer variety of rooms and services to suit your needs and requirements.
Reach out to us across any of our channels.
